2015 Update on Acute Adverse Reactions to Gadolinium based Contrast Agents in Cardiovascular MR. Large Multi-National and Multi-Ethnical Population Experience With 37788 Patients From the EuroCMR Registry

Journal of Cardiovascular Magnetic Resonance

Volumn 17, Issue 1, 2015, Pages

  Bruder, O ^a   Schneider, S ^b   Pilz, G ^c   Van Rossum, A C ^d   Schwitter, J ^e   Nothnagel, D ^f   Lombardi, M ^g   Buss, S ^h   Wagner, A ⁱ   Petersen, S ^j   Greulich, S ^l   Jensen, C ^a   Nagel, E ^k,m   Sechtem, U ^l   Mahrholdt, H ^l  

^a ELISABETH KRANKENHAUS ESSEN   (Germany)

^b Institut fuer Herzinfarktforschung   (Germany)

^c Agatharied Hospital   (Germany)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f KLINIKUM LUDWIGSBURG   (Germany)

^g CNR   (Italy)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ Cardiology Associates of Fairfield   (United States)

^j LONDON CHEST HOSPITAL   (United Kingdom)

^k GOETHE UNIVERSITY   (Germany)

^l ROBERT BOSCH HOSPITAL   (Germany)

^m DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

more..

Author keywords

"Off label use"; Cardiovascular magnetic resonance; Gadolinium; Safety

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOBUTROL; GADODIAMIDE; GADOLINIUM; GADOLINIUM PENTETATE MEGLUMINE; GADOTERATE MEGLUMINE; GADOTERIDOL; CONTRAST MEDIUM;

ADULT; ANXIETY DISORDER; ARTICLE; BODY TEMPERATURE DISORDER; BRADYCARDIA; BRONCHOSPASM; CARDIOPULMONARY ARREST; CARDIOVASCULAR MAGNETIC RESONANCE; CHILL; CONTRAST ENHANCEMENT; CONVULSION; COUGHING; DISEASE SEVERITY; DIZZINESS; DRUG INDICATION; DRUG SAFETY; DYSPNEA; ERYTHEMA; EUROPE; EYE SWELLING; FACE EDEMA; FEMALE; HEADACHE; HEART ARRHYTHMIA; HOT FLUSH; HUMAN; HYPERTENSION; HYPOTENSION; LARYNX EDEMA; MAJOR CLINICAL STUDY; MALE; NAUSEA; NOSE DISEASE; OFF LABEL DRUG USE; PALLOR; PRIORITY JOURNAL; PRURITUS; RADIATION DOSE DISTRIBUTION; RASH; RISK ASSESSMENT; TACHYCARDIA; TASTE DISORDER; URTICARIA; VOMITING; WHEEZING; ACUTE DISEASE; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG SURVEILLANCE PROGRAM; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EPIDEMIOLOGY; ETHNOLOGY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; REGISTER; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

ACUTE DISEASE; ADVERSE DRUG REACTION REPORTING SYSTEMS; CARDIOVASCULAR DISEASES; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EUROPE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84937208631     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/s12968-015-0168-3     Document Type: Article

References (15)

1. Bruder O, Schneider S, Nothnagel D, Pilz G, Lombardi M, Sinha A, et al. Acute adverse reactions to gadolinium-based contrast agents in CMR: multicenter experience with 17,767 patients from the EuroCMR Registry. JACC Cardiovasc Imaging. 2011;4:1171-6.
2. Bruder O, Schneider S, Nothnagel D, Dill T, Nagel E, Lombardi M, et al. European Cardiovascular Magnetic Resonance (EUROCMR) Registry - Preliminary Results of the German Pilot Phase. J Am Coll Cardiol. 2009;54:1457-66.
3. Wagner A, Bruder O, Schneider S, Nothnagel D, Buser P, Pons-Lado P, et al. Current variables, definitions and endpoints of the European cardiovascular magnetic resonance registry. J Cardiovasc Magn Reson. 2009;11:43-50.
4. Bruder O, Wagner A, Lombardi M, Schwitter J, van Rossum A, Pilz G, et al. European Cardiovascular Magnetic Resonance (EuroCMR) registry - multi national results from 57 centers in 15 countries. J Cardiovasc Magn Reson. 2013;15:9.
5. Hendel RC, Patel MR, Kramer CM, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol. 2006;48:1475-97.
6. The American College of Radiology. Manual on contrast media version 6 2008. www.acr.org contrast-manual. Last update: October 6, 2008. Accessed November 24, 2009
7. Nelson KL, Gifford LM, Lauber-Huber C, Gross CA, Lasser TA. Clinical safety of gadopentetate dimeglumine. Radiology. 1995;196:439-43.
8. Murphy KJ, Brunberg JA, Cohan RH. Adverse reactions to gadolinium contrast media: a review of 36 cases. AJR. 1996;167:847-9.
9. Li A, Wong CS, Wong MK, Lee CM, Au Yeung MC. Acute adverse reactions to magnetic reso- nance contrast media: gadolinium chelates. Br J Radiol. 2006;79:368-71.
10. Dillman JR, Ellis JH, Cohan RH, Strouse PJ, Jan SC. Frequency and severity of acute allergic-like reac- tions to gadolinium-containing IV contrast media in children and adults. AJR. 2007;189:1533-8.
11. Bleicher AG, Kanal E. Assessment of adverse re- action rates to a newly approved MRI contrast agent: review of 23,553 administrations of gado- benate dimeglumine. AJR. 2008;191(1870):W307-11.
12. Hunt CH, Hartman RP, Hesley GK. Frequency and severity of adverse effects of iodinated and gadolinium contrast materials: retrospective review of 456,930 doses. Am J Roentgenol. 2009;193:1124-7.
13. Abujudeh HH, Kosaraju VK, Kaewlai R. Acute adverse reactions to gadopentetate dimeglumine and gadobenate dimeglumine: experience with 32,659 injections. Am J Roentgenol. 2010;194:430-4.
14. Prince MR, Zhang H, Zou Z, Staron RB, Brill PW. Incidence of Immediate Gadolinium Contrast Media Reactions. AJR. 2011;196:138-43.
15. Jung JW, Kang HR, Kim MH, Lee W, Min KU, Han MH, et al. Immediate hypersensitivity reaction to gadolinium-based MR contrast media. Radiology. 2012;264(2):414-22.